Zydus Pharmaceuticals erythromycin tablets recalled for elevated nitrosamine impurity

Zydus erythromycin tablets recalled for nitrosamine impurity

Zydus Pharmaceuticals is recalling erythromycin tablets (250 mg) due to the presence of N-Nitroso-Desmethyl-Erythromycin, a nitrosamine impurity, at levels above the FDA's acceptable intake limit. The affected bottles were distributed nationwide. This impurity can potentially increase cancer risk with long-term exposure.

• Check if you have erythromycin from Zydus Pharmaceuticals with one of the recalled lot numbers (M411146, M502098, M502097, or M411145).
• Contact your pharmacist or doctor before stopping your medication.
• Do not throw away your medication; your pharmacist or doctor will advise you on safe disposal or replacement options.